AIIMS New Delhi and C-DAC have unveiled iOncology.ai, an indigenous AI-powered oncology platform to aid early detection, diagnosis, and treatment planning for breast and ovarian cancers in India.

The initiative underscores the importance of collaborative efforts in integrating AI into medical workflows.

Development involved collaboration among oncologists, doctors, pathologists, and AI technologists, with models trained on annotated Indian medical datasets and features like telepathology to support remote diagnoses.

Telepathology was highlighted as a key feature to improve access in remote and smaller districts, enabling digitally rendered consultations with specialists.

The platform, showcased on Digital India Ask Experts, provides AI-driven data insights to clinicians, pathologists, and radiologists for faster, evidence-based decisions.

iOncology.ai is integrated with the Ayushman Bharat Digital Mission ecosystem, consolidating patient data into a secure, role-based access dashboard for healthcare professionals.

Experts stressed the importance of early cancer detection and cautioned against self-medication or relying on generic AI tools for medical decisions without qualified professional input.

Key participants in the discussion included Lakshmi Panat of C-DAC, Prof Ashok Sharma of AIIMS New Delhi, and Dr. Fouzia Siraj of ICMR-Centre for Cancer Pathology.

The roadmap for iOncology.ai envisions digital twin technology to model patient treatment responses and the integration of multi-omics data to enable more personalized cancer care.